BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34128847)

  • 1. Clinicopathological analysis and genomic profiling of a rare histiocyte-rich rhabdomyoblastic tumor: A case report.
    Xia Y; Li Y; Gong P; Jiang H; Zhang X
    Medicine (Baltimore); 2021 Jun; 100(24):e26105. PubMed ID: 34128847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms.
    Martinez AP; Fritchie KJ; Weiss SW; Agaimy A; Haller F; Huang HY; Lee S; Bahrami A; Folpe AL
    Mod Pathol; 2019 Mar; 32(3):446-457. PubMed ID: 30287926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnoses.
    Bourgeau M; Martinez AP
    Virchows Arch; 2021 Feb; 478(2):367-373. PubMed ID: 32514584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor".
    Cloutier JM; Charville GW; Mertens F; Sukov W; Fritchie K; Perry KD; Edgar M; Rowsey RA; Folpe AL
    Mod Pathol; 2021 Apr; 34(4):758-769. PubMed ID: 33318583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of A Low-Grade Inflammatory Leiomyosarcoma/Histiocyte-Rich Rhabdomyoblastic Tumor in the Neck of An Adolescent Male.
    Rekhi B; Bal M; Dharavath B; Dutt A; Pai P
    Turk Patoloji Derg; 2023; 39(2):154-160. PubMed ID: 35642345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
    Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
    Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histiocyte-rich rhabdomyoblastic tumor: a clinicopathological and molecular genetic analysis].
    You ZJ; Kong LY; Wang C; Chen X; Chen XB; Yu X
    Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):425-430. PubMed ID: 35511638
    [No Abstract]   [Full Text] [Related]  

  • 8. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.
    Dehner CA; Geiersbach K; Rowsey R; Murugan P; Broski SM; Meis JM; Rosenberg AE; Folpe AL
    Mod Pathol; 2023 Jun; 36(6):100131. PubMed ID: 36966552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
    Folpe AL; McKenney JK; Bridge JA; Weiss SW
    Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
    Hornick JL; Nielsen GP
    Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
    Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
    Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current landscape of rhabdomyosarcomas: an update.
    Leiner J; Le Loarer F
    Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-needle aspiration biopsy diagnosis of histiocyte-rich rhabdomyoblastic tumor (inflammatory leiomyosarcoma): A case report.
    McHugh KE; Kilpatrick SE
    Diagn Cytopathol; 2023 Apr; 51(4):E109-E112. PubMed ID: 36519516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
    Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
    Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies.
    Seidal T; Kindblom LG; Angervall L
    Appl Pathol; 1987; 5(4):201-19. PubMed ID: 3689591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
    Liu L; Wang LH; Ren YB; Rao XS; Yang SM
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159
    [No Abstract]   [Full Text] [Related]  

  • 19. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma.
    Bishop JA; Thompson LD; Cardesa A; Barnes L; Lewis JS; Triantafyllou A; Hellquist H; Stenman G; Hunt JL; Williams MD; Slootweg PJ; Devaney KO; Gnepp DR; Wenig BM; Rinaldo A; Ferlito A
    Head Neck Pathol; 2015 Dec; 9(4):507-18. PubMed ID: 25757816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.